| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,301 |
5,059 |
$603K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,456 |
3,613 |
$365K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,743 |
1,649 |
$178K |
| 99215 |
Prolong outpt/office vis |
914 |
814 |
$134K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,608 |
1,326 |
$133K |
| 90846 |
Family psychotherapy without the patient present, 50 minutes |
1,414 |
1,306 |
$124K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,151 |
1,091 |
$119K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
965 |
817 |
$114K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
498 |
474 |
$57K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,398 |
1,208 |
$52K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,070 |
2,466 |
$35K |
| 90658 |
|
1,437 |
1,321 |
$29K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
215 |
201 |
$29K |
| 92551 |
|
2,208 |
2,101 |
$20K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
816 |
735 |
$18K |
| 90670 |
|
888 |
811 |
$17K |
| 96127 |
|
2,469 |
2,281 |
$15K |
| 90698 |
|
623 |
575 |
$12K |
| 90680 |
|
521 |
460 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
673 |
326 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
122 |
108 |
$7K |
| 90633 |
|
330 |
314 |
$7K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
398 |
348 |
$5K |
| 92550 |
|
224 |
166 |
$4K |
| 2015F |
|
377 |
312 |
$4K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
385 |
371 |
$4K |
| 90687 |
|
165 |
160 |
$4K |
| 81000 |
|
1,059 |
1,024 |
$3K |
| 99177 |
|
711 |
661 |
$3K |
| 96160 |
|
1,307 |
1,150 |
$3K |
| 90744 |
|
178 |
159 |
$3K |
| 86328 |
|
74 |
69 |
$3K |
| 92567 |
|
190 |
154 |
$3K |
| 99173 |
|
1,194 |
1,150 |
$3K |
| 90656 |
|
151 |
140 |
$3K |
| 90677 |
|
127 |
107 |
$3K |
| 90686 |
|
164 |
128 |
$3K |
| 90697 |
|
151 |
127 |
$3K |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
345 |
292 |
$2K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
126 |
116 |
$2K |
| 90651 |
|
38 |
38 |
$1K |
| 0001A |
|
41 |
37 |
$1K |
| 90655 |
|
41 |
40 |
$884.84 |
| 96161 |
|
340 |
307 |
$859.59 |
| 94760 |
|
338 |
296 |
$755.82 |
| 90619 |
|
24 |
24 |
$592.32 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
74 |
62 |
$558.38 |
| 90734 |
|
27 |
25 |
$554.88 |
| 94664 |
|
91 |
83 |
$476.00 |
| 83655 |
|
60 |
42 |
$455.67 |
| 0002A |
|
13 |
13 |
$420.00 |
| 0064A |
|
12 |
12 |
$390.00 |
| 90715 |
|
12 |
12 |
$363.04 |
| 90685 |
|
19 |
19 |
$325.92 |
| 90648 |
|
18 |
15 |
$302.64 |
| 87400 |
|
34 |
23 |
$255.42 |
| 99051 |
|
20 |
20 |
$180.00 |
| 3008F |
|
90 |
83 |
$145.00 |
| 36416 |
|
122 |
87 |
$120.00 |
| 85018 |
|
79 |
58 |
$106.46 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
52 |
46 |
$96.27 |
| 3011F |
|
12 |
12 |
$90.00 |
| 99072 |
|
382 |
309 |
$23.28 |
| M1207 |
Patient is screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety |
208 |
192 |
$18.00 |
| G0008 |
Administration of influenza virus vaccine |
116 |
99 |
$0.00 |
| 99441 |
|
12 |
12 |
$0.00 |
| 99402 |
|
15 |
14 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
41 |
20 |
$0.00 |
| 90461 |
|
22 |
12 |
$0.00 |
| 99401 |
|
20 |
12 |
$0.00 |